Enteric fever, predominantly caused by Salmonella Typhi and Salmonella Paratyphi, is a systemic illness that continues to pose significant health challenges globally. This article presents a comprehensive and updated approach to the diagnosis and treatment of this disease.
Traditionally, the diagnosis of enteric fever has relied heavily on blood culture which, despite being the gold standard, has a sensitivity of only 40-60%. Recent advancements in molecular diagnostics, such as Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS), have shown promise in improving diagnostic accuracy. These techniques can detect bacterial DNA directly from patient samples, thereby increasing sensitivity and specificity. Serology tests, such as the Widal test, though less reliable, may be used in resource-limited settings.
Antibiotic therapy remains the mainstay of treatment for enteric fever. However, the emergence of multi-drug resistant strains necessitates careful antibiotic selection. Current guidelines recommend third-generation cephalosporins, such as ceftriaxone or cefixime, or fluoroquinolones, like ciprofloxacin, for initial empirical therapy. In cases of confirmed multi-drug resistance, azithromycin has shown efficacy. It is crucial to adjust therapy based on culture and sensitivity results to prevent treatment failure and further resistance.
Prevention strategies include improved sanitation, safe food and water practices, and vaccination. Two vaccines, Ty21a (oral) and Vi polysaccharide (injectable), are available and recommended for high-risk populations and travelers to endemic areas. However, vaccination should not replace basic hygiene practices as it provides only moderate protection.
Enteric fever remains a significant health burden, particularly in low-resource settings. While diagnostic and treatment strategies continue to evolve, emphasis should be placed on prevention and control measures to reduce the incidence of this disease. Healthcare professionals should stay abreast of current guidelines and advances to provide optimal patient care.
1.
Toxic fungus from King Tutankhamun's tomb yields cancer-fighting compounds—new study
2.
Study shows virtual reality headsets may help ease cancer pain
3.
Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer
4.
Spouses of Cancer Patients May Be at Increased Risk of Suicide
5.
Study finds 81% of cancer cures touted by TikTok videos are fake
1.
Personalized Survivorship Navigation in Precision Cancer Care
2.
The Essential Guide to Understanding Fibrinogen and Its Role in Blood Clotting
3.
Mechanistic Depth and Clinical Impact of Rusfertide, Onyvide, IV Avastin, and Pemfexy
4.
Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care
5.
Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
How Nutrition Can Support Patients During Cancer Care
2.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
3.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
4.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
5.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation